DARE Dare Bioscience, Inc. - Common Stock
NASDAQ · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 13, 2026
$0,84
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,6952 haftanın en düşüğü
$3,7852 haftanın en yükseği
Piyasa Değeri (MRQ)
$13M
P/E (TTM)
-1.3
Hisse Başına Kâr (TTM)
$-0.66
Gelir (TTM)
$1M
rozetleriniz
52 Haftlık Aralık
$1–$4
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$8
P/E
-1.3
ROE
165.3%
Net Kâr Marjı
-804.4%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
DARE Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.84
Piyasa Değeri (MRQ)
$13M
P/E (TTM)
-1.3
Hisse Başına Kâr (TTM)
$-0.66
Gelir (TTM)
$1M
ROE (TTM)
165.3%
52 Haftlık Aralık
$1–$4
DARE Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 01 Temmuz 2024 | 1-for-12 | Ters |
| 20 Temmuz 2017 | 1-for-10 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$1M2016-12-31 → 2025-12-31
Hisse Başına Kâr$-1.202020-12-31 → 2025-12-31
Serbest Nakit Akışı$-10M2016-12-31 → 2025-12-31
Net kar marjı-804.4%2016-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | DARE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -1.35Y ort. ≈-14.8 | ≈-14.8 | · | · | |
| F/S (TTM) | 9.45Y ort. ≈754.5 | ≈754.5 | 18.4 | Aşırı değerli | |
| F/D (MRQ) | -22.85Y ort. ≈12.0 | ≈12.0 | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | -1.15Y ort. ≈-24.6 | ≈-24.6 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -1.15Y ort. ≈-24.8 | ≈-24.8 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 4.35Y ort. ≈46.0 | ≈46.0 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | DARE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -813.4%5Y ort. ≈-60605.9% | ≈-60605.9% | -1538.8% | Aynı seviyede | |
| FAVÖK Marjı (TTM) | -656.5%5Y ort. ≈-60566.2% | ≈-60566.2% | -1495.1% | Zayıf | |
| Pretax Margin (Vergi Öncesi Kar Marjı) | -1314.4%5Y ort. ≈-11028.1% | ≈-11028.1% | -998.5% | Zayıf | |
| Net Kâr Marjı (TTM) | -804.4%5Y ort. ≈-11028.8% | ≈-11028.8% | -1379.6% | Zayıf | |
| ROA (TTM) | -62.2%5Y ort. ≈-68.9% | ≈-68.9% | -49.1% | Aynı seviyede | |
| ROE (TTM) | 165.3%5Y ort. ≈185.3% | ≈185.3% | -57.8% | En üst düzey | |
| ROIC | -476.8%5Y ort. ≈28.6% | ≈28.6% | 145.2% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | DARE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 1.05Y ort. ≈1.5 | ≈1.5 | 3.1 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 1.05Y ort. ≈1.3 | ≈1.3 | 2.1 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | DARE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 10429.4%5Y ort. ≈3419.3% | ≈3419.3% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -53.1% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | DARE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.05Y ort. ≈0.1 | ≈0.1 | 0.1 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$49.1K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
27.3%
Sonraki Rapor
Kas 11, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 13, 2026 | $-0.20 | $-0.25 | 20.0% |
| 31 Mart 2026 | May 14, 2026 | $-0.20 | $-0.30 | 32.4% |
| 31 Aralık 2025 | $-0.02 | $-0.44 | 95.5% | |
| 30 Eylül 2025 | $-0.28 | $-0.36 | 23.0% | |
| 30 Haziran 2025 | $-0.45 | $-0.59 | 23.9% | |
| 31 Mart 2025 | $-0.50 | $-0.59 | 15.5% | |
| 31 Aralık 2024 | $-0.65 | $-0.54 | -19.5% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $9.8K | $3M | $10M | $0 | · | · | · | · | $766.0K | · | $80.0K | |
| Cost of Revenue | $295.8K | $0 | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $6M | $14M | $22M | $30M | $31M | $21M | $9M | $6M | $984.7K | $72.7K | $26M | $12M | |
| SG&A Expense | $9M | $9M | $12M | $11M | $8M | $7M | $5M | $5M | $3M | $157.9K | $11M | $9M | |
| Operating Expenses | $14M | $23M | $34M | $41M | $39M | $27M | $14M | $17M | $11M | $630.6K | $37M | $20M | |
| Operating Income | $-14M | $-23M | $-31M | $-31M | $-39M | $-27M | $-14M | $-17M | $-11M | $-630.6K | · | · | |
| Interest Expense | · | · | · | · | · | · | · | · | $322.6K | $42.1K | $2M | $1M | |
| Interest Income | · | · | · | · | · | · | · | · | · | $86.0K | $10.0K | $9.0K | |
| Other Non-op | $-153.1K | $981.5K | $778.5K | $437.8K | $2.5K | $1.5K | $81.0K | $143.5K | $-322.6K | $-2M | $-2M | $-3M | |
| Pretax Income | $-14M | $-4M | $-30M | $-31M | $-39M | $-27M | $-14M | $-17M | $-12M | $-673.0K | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.2K | $0 | · | · | · | |
| Net Income | $-13M | $-4M | $-30M | $-31M | $-39M | $-27M | $-14M | $-17M | $-12M | $-672.7K | $-40M | $-23M | |
| EPS (Basic) | $-1.20 | $-0.48 | $-4.15 | $-0.37 | $-0.63 | $-0.91 | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.20 | $-0.48 | $-4.15 | $-0.37 | $-0.63 | $-0.91 | · | · | · | · | · | · | |
| Shares (Basic) | 11,178,752 | 8,497,459 | 7,275,308 | 84,571,805 | 61,154,157 | 30,091,469 | · | · | 3,232,278 | 835,000 | · | · | |
| Shares (Diluted) | 11,178,752 | 8,497,459 | 7,275,308 | 84,571,805 | 61,154,157 | 30,091,469 | · | · | 3,232,278 | 835,000 | · | · | |
| EBITDA | $-12M | $-23M | $-31M | $-31M | $-39M | $-27M | $-14M | $-17M | · | $261.0K | $192.0K | $126.0K |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $16M | $10M | $35M | $52M | $5M | $5M | $7M | $8M | $44.6K | $219.4K | $51M | |
| Receivables | · | · | · | · | $0 | · | · | · | · | $823.0K | · | · | |
| Prepaid Expense | $387.1K | $3M | $6M | $7M | $2M | $2M | $1M | $403.1K | $311.6K | $1M | · | · | |
| Other Current Assets | $573.1K | $0 | $0 | $0 | · | · | · | $0 | $193.5K | · | · | · | |
| Current Assets | $27M | $18M | $18M | $43M | $55M | $7M | $6M | $7M | $8M | $44.6K | $77M | $53M | |
| PP&E (Net) | $2M | $1M | $656.0K | $64.9K | $26.0K | $37.9K | $63.5K | $9.4K | $0 | $668.0K | $576.0K | $342.0K | |
| PP&E (Gross) | $2M | $2M | $801.7K | · | · | · | · | · | · | $2M | $2M | $2M | |
| Accum. Depreciation | $338.0K | $175.9K | $145.7K | · | · | · | · | · | · | $1M | $1M | $1M | |
| Goodwill | · | · | · | · | · | · | · | $0 | $5M | · | · | · | |
| Other Non-current Assets | $1M | $1M | $599.6K | $254.3K | $485.1K | $528.9K | $935.3K | $578.0K | $723.2K | $12.7K | $347.0K | $215.0K | |
| Total Assets | $32M | $22M | $21M | $44M | $56M | $8M | $7M | $8M | $14M | $44.6K | $78M | $53M | |
| Accounts Payable | $1M | $1M | $3M | $2M | $2M | $1M | $1M | $459.7K | $308.2K | $12.7K | $2M | $1M | |
| Accrued Liabilities | $725.2K | $3M | $3M | $11M | $3M | $3M | $2M | $631.4K | $658.4K | $5M | $6M | $4M | |
| Short-term Debt | · | · | · | · | $0 | $367.3K | $0 | · | · | · | · | · | |
| Current Liabilities | $24M | $22M | $20M | $32M | $16M | $8M | $6M | $1M | $966.7K | $755.2K | $16M | $8M | |
| Capital Leases | $559.4K | $754.4K | $935.7K | $90.3K | $0 | $41.8K | $389.6K | $389.0K | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $0 | $41.8K | $389.6K | $9.7K | · | $1M | $473.0K | $7.0K | |
| Total Liabilities | $30M | $28M | $26M | $33M | $17M | $9M | $7M | $1M | $967.0K | $755.2K | · | · | |
| Total Debt | · | · | · | · | $0 | $367.3K | · | · | · | · | · | · | |
| Common Stock | $1.4K | $870 | $833 | $8.5K | $8.4K | $4.2K | $2.0K | $1.1K | $605 | $91 | $3.0K | $2.0K | |
| Paid-in Capital | $192M | · | · | · | · | · | · | · | · | · | · | $167M | |
| Retained Earnings | $-189M | $-175M | $-171M | $-141M | $-110M | $-71M | $-44M | $-29M | $-12M | $-727.8K | $-161M | $-122M | |
| AOCI | $-421.6K | $-428.8K | $-360.9K | $-351.3K | $-155.0K | $-91.4K | $-102.6K | $-96.7K | $-18.1K | · | · | · | |
| Stockholders' Equity | $3M | $-6M | $-5M | $11M | $39M | $-1M | $440.8K | $7M | $13M | $-710.6K | $-46.9K | $45M | |
| Liabilities + Equity | $32M | $22M | $21M | $44M | $56M | $8M | $7M | $8M | $14M | $44.6K | $78M | $53M | |
| Shares Outstanding | 14,499,502 | 8,700,386 | 8,331,161 | 7,068,790 | 83,944,119 | 41,596,253 | 19,683,401 | 11,422,161 | 6,047,161 | 910,000 | 27,346,780 | 20,125,049 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $42.3K | · | · | · | · | · | · | · | $261.0K | $192.0K | $126.0K | |
| Stock-based Comp | $1M | $2M | $3M | $2M | $2M | $742.0K | $462.2K | $139.3K | $15.8K | $9.0K | $2M | $885.0K | |
| Other Non-cash | $382.4K | · | · | · | · | · | · | · | · | $3M | $5M | $3M | |
| Operating Cash Flow | $-10M | $5M | $-39M | $-18M | $-29M | $-25M | $-13M | $-10M | $-3M | $-372.3K | $-32M | $-19M | |
| CapEx | $385.3K | $573.0K | $629.4K | $63.1K | $14.5K | $17.6K | $0 | $11.8K | $0 | $535.0K | $277.0K | $225.0K | |
| Investing Cash Flow | $-385.3K | $-573.0K | $-629.4K | $-63.1K | $-14.5K | $-17.6K | $6M | $-518.8K | $10M | · | · | · | |
| Stock Issued | $21M | $453.6K | · | $1M | $16M | $23M | $5M | · | · | $918.0K | $3M | $140.0K | |
| Net Stock Activity | $21M | · | · | $1M | $16M | $23M | · | · | · | $918.0K | $3M | $140.0K | |
| Financing Cash Flow | $19M | $354.5K | $16M | $1M | $76M | $25M | $5M | $10M | $155.0K | · | · | · | |
| Net Change in Cash | $9M | $5M | $-24M | $-17M | $47M | $-110.6K | $-2M | $-754.0K | $8M | $-174.8K | $25M | $46M | |
| Free Cash Flow | $-10M | $5M | $-39M | $-18M | $-29M | $-25M | $-13M | $-10M | · | $-34M | $-32M | $-19M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1315.5% | -239692.2% | -1101.9% | -313.9% | · | · | · | · | · | · | · | · | |
| Net Margin | -1300.7% | -41430.9% | -1074.2% | -309.5% | · | · | · | · | · | -5131.2% | · | -29177.5% | |
| Pretax Margin | -1314.4% | -41414.6% | -1074.1% | -309.5% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1156.9% | -239692.2% | -1101.9% | -313.9% | · | · | · | · | · | 34.1% | · | 157.5% | |
| ROA | -49.1% | -18.7% | -92.7% | -62.1% | -122.2% | -365.5% | -186.8% | -151.6% | · | -67.8% | -60.2% | -77.5% | |
| ROE | 270.9% | 108.1% | 822.2% | -165.2% | -109.5% | 2159.6% | -1267.4% | -205.3% | · | -601.7% | -84.2% | 95.3% | |
| ROIC | -476.8% | 390.1% | 613.0% | -282.4% | -100.8% | 3493.2% | -3254.1% | -251.0% | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 0.9 | 0.9 | 1.4 | 3.4 | 0.9 | 1.1 | 6.6 | · | 2.2 | 4.7 | 6.6 | |
| Quick Ratio | 1.0 | 0.7 | 0.5 | 1.1 | 3.2 | 0.6 | 0.9 | 6.2 | · | 2.1 | 4.6 | 6.3 | |
| Debt / Equity | · | · | · | · | 0.0 | -0.3 | · | · | · | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.1 | 0.2 | · | · | · | · | · | 0.0 | · | 0.0 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.20 | $-0.69 | $-0.05 | $0.13 | $0.46 | $-0.03 | $0.02 | $0.59 | · | $0.45 | $1.78 | $2.25 | |
| Revenue / Share | $0.09 | $0.00 | $0.03 | $0.12 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.88 | $0.63 | $-0.45 | $-0.21 | $-0.47 | · | · | · | · | · | · | · | |
| Cash / Share | $1.70 | $1.80 | $0.10 | $0.41 | $0.62 | $0.11 | $0.24 | $0.60 | · | $1.21 | $2.78 | $2.54 | |
| EPS (TTM) | $-1.20 | $-0.48 | $-4.15 | $-0.37 | $-0.63 | $-0.91 | · | · | · | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10429.4% | -99.7% | -71.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -53.1% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $9.8K | $3M | $10M | $0 | · | · | · | · | $766.0K | · | $80.0K | |
| Net Income TTM | $-13M | $-4M | $-30M | $-31M | $-39M | $-27M | $-14M | $-17M | $-12M | $-672.7K | $-40M | $-23M | |
| Market Cap | $28M | $27M | $371M | $845M | $2.01B | $669M | $194M | $97M | · | $2.46B | $9.19B | $15.02B | |
| Enterprise Value | · | · | · | · | $1.96B | $665M | · | · | · | · | · | · | |
| P/E | -1.6 | -6.5 | -0.9 | -26.9 | -38.1 | -17.7 | · | · | · | · | · | · | |
| P/S | 27.2 | 2774.4 | 132.0 | 84.5 | · | · | · | · | · | 3209.5 | · | 187766.7 | |
| P/B | 9.8 | -4.5 | -73.4 | 76.0 | 52.0 | -580.7 | 439.4 | 14.5 | · | 187.5 | 188.5 | 331.4 | |
| P / Tangible Book | 9.8 | · | · | 76.0 | 52.0 | · | · | · | · | · | · | · | |
| P / Cash Flow | -2.8 | 5.0 | -9.5 | -46.7 | -70.0 | -26.5 | -14.5 | -9.5 | · | -73.3 | -287.9 | -788.1 | |
| P / FCF | -2.7 | 5.6 | -9.4 | -46.5 | -70.0 | -26.5 | -14.5 | -9.5 | · | -72.2 | -285.4 | -778.9 | |
| EV / EBITDA | · | · | · | · | -50.2 | -24.3 | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | -68.2 | -26.3 | · | · | · | · | · | · | |
| Earnings Yield | -62.2% | -15.4% | -111.9% | -3.7% | -2.6% | -5.7% | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $187.5K | $152.5K | $1M | $2.3K | $-21.2K | $25.4K | $-63.6K | $41.7K | $22.4K | $9.3K | $2M | $1M | $0 | $0 | $0 | $0 | |
| Cost of Revenue | $319.9K | $242.3K | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $242.0K | $660.5K | $622.0K | $1M | $1M | $2M | $3M | $3M | $5M | $3M | $4M | $7M | $6M | $5M | $13M | $4M | |
| SG&A Expense | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $3M | $3M | $2M | $4M | $4M | $5M | $5M | $5M | $7M | $6M | $7M | $9M | $9M | $8M | $16M | $7M | |
| Operating Income | $-3M | $-3M | $-1M | $-4M | $-4M | $-5M | $-5M | $-5M | $-7M | $-6M | $-5M | $-8M | $-9M | $-8M | $-16M | $-7M | |
| Other Non-op | $-14.8K | $-991 | $-276.6K | $109.4K | $-188.7K | $202.8K | $2M | $-21.2K | $-109.3K | $-732.9K | $113.9K | $97.3K | $227.1K | $340.1K | $287.3K | $119.0K | |
| Net Income | $-3M | $-3M | $-1M | $-4M | $-4M | $-4M | $-6M | $-5M | $13M | $-7M | $-5M | $-8M | $-9M | $-8M | $-16M | $-7M | |
| EPS (Basic) | $-0.20 | $-0.21 | $0.03 | $-0.28 | $-0.45 | $-0.50 | $-0.65 | $-0.55 | $1.53 | $-0.81 | $-1.75 | $-1.09 | $-1.22 | $-0.09 | $-0.19 | $-0.08 | |
| EPS (Diluted) | $-0.20 | $-0.21 | $0.03 | $-0.28 | $-0.45 | $-0.50 | $-0.64 | $-0.55 | $1.52 | $-0.81 | $-1.75 | $-1.09 | $-1.22 | $-0.09 | $-0.19 | $-0.08 | |
| Shares (Basic) | 14,889,832 | 14,522,835 | · | 12,755,112 | 8,871,155 | 8,759,053 | · | 8,534,433 | 8,411,242 | 8,376,189 | · | 7,587,637 | 7,200,260 | 85,517,540 | · | 84,822,516 | |
| Shares (Diluted) | 14,889,832 | 14,522,835 | · | 12,755,112 | 8,871,155 | 8,759,053 | · | 8,534,433 | 8,476,231 | 8,376,189 | · | 7,587,637 | 7,200,260 | 85,517,540 | · | 84,822,516 | |
| EBITDA | $-3M | $-2M | · | $-4M | $-4M | $-4M | · | $-5M | $-7M | $-6M | · | $-8M | $-9M | $-8M | · | $-7M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $19M | $25M | $23M | $5M | $10M | $16M | $11M | $16M | $4M | $10M | $14M | $13M | $20M | $35M | $40M | |
| Prepaid Expense | $835.4K | $680.8K | $2M | $2M | $1M | $1M | $3M | $3M | $4M | $5M | $6M | $7M | $8M | $7M | $7M | $7M | |
| Other Current Assets | $456.4K | $687.8K | · | $53.2K | · | · | · | · | · | $152.2K | · | $831.4K | $272.1K | $201.4K | · | · | |
| Current Assets | $17M | $22M | $27M | $25M | $7M | $12M | $18M | $15M | $21M | $10M | $18M | $22M | $22M | $30M | $43M | $50M | |
| PP&E (Net) | $1M | $1M | $2M | $2M | $2M | $1M | $1M | $706.3K | $322.3K | $52.5K | $656.0K | $58.6K | $45.8K | $55.4K | $64.9K | $72.8K | |
| PP&E (Gross) | · | · | $2M | · | · | · | $2M | · | · | · | $801.7K | · | · | · | · | · | |
| Accum. Depreciation | · | · | $338.0K | · | · | · | $175.9K | · | · | · | $145.7K | · | · | · | · | · | |
| Other Non-current Assets | $3M | $2M | $1M | $1M | $1M | $1M | $1M | $533.9K | $528.6K | $654.5K | $599.6K | $796.4K | $920.9K | $799.3K | $254.3K | $736.5K | |
| Total Assets | $22M | $28M | $32M | $31M | $13M | $19M | $22M | $18M | $24M | $13M | $21M | $25M | $23M | $30M | $44M | $50M | |
| Accounts Payable | $762.9K | $1M | $1M | $2M | $2M | $2M | $1M | $1M | $2M | $4M | $3M | $5M | $7M | $3M | $2M | $3M | |
| Accrued Liabilities | $448.9K | $529.3K | $725.2K | $2M | $3M | $2M | $3M | $2M | $1M | $1M | $3M | $5M | $4M | $5M | $11M | $4M | |
| Current Liabilities | $17M | $21M | $24M | $21M | $19M | $21M | $22M | $13M | $15M | $18M | $20M | $26M | $25M | $24M | $32M | $23M | |
| Capital Leases | $273.9K | $418.3K | $559.4K | $288.6K | $448.2K | $603.3K | $754.4K | $897.8K | $1M | $1M | $935.7K | $0 | $23.3K | $57.1K | $90.3K | $194.6K | |
| Total Liabilities | $23M | $27M | $30M | $28M | $26M | $28M | $28M | $20M | $21M | $24M | $26M | $27M | $26M | $25M | $33M | $24M | |
| Total Debt | · | · | · | $10.5K | $188.0K | $91.9K | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $1.5K | $1.5K | $1.4K | $1.4K | $903 | $885 | $870 | $854 | $854 | $10.1K | $833 | $9.8K | $8.7K | $8.6K | $8.5K | $8.5K | |
| Paid-in Capital | $194M | $193M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-195M | $-192M | $-189M | $-187M | $-184M | $-180M | $-175M | $-170M | $-165M | $-178M | $-171M | $-166M | $-158M | $-149M | $-141M | $-125M | |
| AOCI | $-374.9K | $-377.1K | $-421.6K | $-396.0K | $-402.8K | $-415.7K | $-428.8K | $-362.6K | $-385.6K | $-400.1K | $-360.9K | $-419.5K | $-404.5K | $-373.3K | $-351.3K | $-530.7K | |
| Stockholders' Equity | $-560.1K | $734.5K | $3M | $3M | $-13M | $-10M | $-6M | $-1M | $3M | $-11M | $-5M | $-2M | $-3M | $5M | $11M | $26M | |
| Liabilities + Equity | $22M | $28M | $32M | $31M | $13M | $19M | $22M | $18M | $24M | $13M | $21M | $25M | $23M | $30M | $44M | $50M | |
| Shares Outstanding | 15,169,502 | 14,559,502 | 14,499,502 | 13,929,502 | 9,030,386 | 8,850,386 | 8,700,386 | 8,546,364 | 8,546,361 | 100,581,900 | 8,331,161 | 98,292,344 | 86,633,588 | 86,178,996 | 84,825,481 | 83,944,119 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $572.1K | $554.6K | $534.4K | $481.9K | $460.1K | $175.6K | $6.4K | $9.7K | $15.4K | $10.8K | · | · | · | · | · | · | |
| Stock-based Comp | $286.6K | $455.1K | $357.2K | $403.0K | $359.0K | $377.4K | $489.3K | $523.6K | $562.7K | $627.7K | $619.8K | $636.1K | $650.2K | $624.6K | $532.1K | $556.4K | |
| Other Non-cash | · | $-4M | · | · | · | $-2M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-7M | $-6M | $1M | $-442.1K | $-5M | $-5M | $5M | $-6M | $13M | $-7M | $-8M | $-8M | $-7M | $-16M | $-6M | $9M | |
| CapEx | $80.6K | $0 | $206.6K | $174.7K | $-153.4K | $157.3K | $562.8K | $-282.3K | $285.2K | $7.3K | $607.3K | $22.1K | $0 | $0 | $2.7K | $55.0K | |
| Investing Cash Flow | $-80.6K | $0 | $-206.6K | $-174.7K | $153.4K | $-157.3K | $-562.8K | $282.3K | $-285.2K | $-7.3K | $-607.3K | $-22.1K | $0 | $0 | $-2.7K | $-55.0K | |
| Stock Issued | $166.7K | $94.9K | · | · | $475.0K | $436.2K | · | · | · | · | · | · | · | · | · | $0 | |
| Net Stock Activity | · | $94.9K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $951.2K | $-715.5K | $424.1K | $19M | $-43.8K | $246.6K | $-211.3K | $436.4K | $115.4K | $14.0K | $5M | $9M | $452.2K | $1M | $-1 | $4.5K | |
| Net Change in Cash | $-6M | $-6M | $2M | $18M | $-5M | $-5M | $4M | $-5M | $13M | $-7M | $-3M | $565.3K | $-6M | $-15M | $-6M | $8M | |
| Free Cash Flow | · | $-6M | · | · | · | $-6M | · | · | · | $-7M | · | · | · | $-16M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1582.5% | -1967.1% | · | -162340.8% | · | -18016.8% | · | -11228.7% | -32799.1% | -64743.8% | · | -839.6% | · | · | · | · | |
| Net Margin | -1590.4% | -1967.7% | · | -157505.1% | · | -17219.1% | · | -11279.4% | 57539.3% | -72622.6% | · | -829.9% | · | · | · | · | |
| EBITDA Margin | -1582.5% | -1603.3% | · | -162340.8% | · | -17394.9% | · | -11228.7% | -32799.1% | -64743.8% | · | -839.6% | · | · | · | · | |
| ROA | -16.9% | -12.9% | · | -14.6% | -22.0% | -27.7% | · | -21.8% | 55.1% | -31.1% | · | -22.0% | -23.5% | -20.2% | · | -14.1% | |
| ROE | 44.9% | 68.0% | · | -518.8% | 79.8% | 42.6% | · | 249.3% | -53911.2% | 224.1% | · | -69.0% | -57.8% | -44.9% | · | -24.1% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 1.0 | · | 1.2 | 0.3 | 0.6 | · | 1.1 | 1.4 | 0.6 | · | 0.9 | 0.9 | 1.2 | · | 2.2 | |
| Quick Ratio | 0.7 | 0.9 | · | 1.1 | 0.3 | 0.5 | · | 0.9 | 1.1 | 0.2 | · | 0.5 | 0.5 | 0.8 | · | 1.8 | |
| Debt / Equity | · | · | · | 0.0 | -0.0 | -0.0 | · | · | · | · | · | · | · | · | · | · |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | 0.0 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.04 | $0.05 | · | $0.21 | $-1.41 | $-1.08 | · | $-0.17 | $0.31 | $-0.11 | · | $-0.02 | $-0.03 | $0.06 | · | $0.31 | |
| Revenue / Share | $0.01 | $0.01 | · | $0.00 | · | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.01 | $0.00 | · | · | $0.00 | |
| Cash Flow / Share | · | $-0.38 | · | · | · | $-0.62 | · | · | · | $-0.07 | · | · | · | $-0.19 | · | · | |
| Cash / Share | $0.83 | $1.27 | · | $1.66 | $0.56 | $1.17 | · | $1.31 | $1.92 | $0.04 | · | $0.14 | $0.15 | $0.23 | · | $0.48 | |
| EPS (TTM) | $-0.66 | $-0.91 | · | $-1.87 | $-2.14 | $-0.17 | · | $-1.59 | $-2.13 | $-4.87 | · | $-2.59 | $-1.58 | $-0.36 | · | $-0.29 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $1M | · | $-57.1K | $-17.7K | $25.9K | · | $2M | $3M | $3M | · | $1M | $0 | $10M | · | · | |
| Net Income TTM | $-11M | $-12M | · | $-17M | $-19M | $-2M | · | $-4M | $-7M | $-29M | · | $-41M | $-40M | $-31M | · | $-25M | |
| Market Cap | $32M | $26M | · | $29M | $22M | $26M | · | $28M | $34M | $591M | · | $545M | $946M | $1.08B | · | $1.01B | |
| Enterprise Value | · | · | · | $6M | $17M | $15M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -3.2 | -2.0 | · | -1.1 | -1.1 | -17.0 | · | -2.0 | -1.9 | -1.2 | · | -2.1 | -6.9 | -34.7 | · | -41.4 | |
| P/S | 23.4 | 22.9 | · | -512.0 | -1219.3 | 987.2 | · | 14.7 | 12.1 | 209.9 | · | 544.9 | · | 107.6 | · | · | |
| P/B | -57.1 | 36.1 | · | 10.2 | -1.7 | -2.7 | · | -18.7 | 12.9 | -53.8 | · | -238.1 | -347.9 | 216.3 | · | 38.2 | |
| P / Tangible Book | · | 36.1 | · | 10.2 | · | · | · | · | 12.9 | · | · | · | · | 216.3 | · | 38.2 | |
| P / Cash Flow | · | -4.8 | · | · | · | -4.7 | · | · | · | -86.8 | · | · | · | -66.7 | · | · | |
| EV / Revenue | · | · | · | -108.3 | -945.5 | 592.1 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -31.3% | -50.0% | · | -89.0% | -89.5% | -5.9% | · | -49.1% | -52.8% | -82.8% | · | -46.7% | -14.5% | -2.9% | · | -2.4% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $1M | $9.8K | $3M | $10M | $0 |
| Faaliyet Kâr Marjı % | -1315.5% | -239692.2% | -1101.9% | -313.9% | · |
| Net Gelir | $-13M | $-4M | $-30M | $-31M | $-39M |
| Seyreltilmiş Hisse Başı Kâr | $-1.20 | $-0.48 | $-4.15 | $-0.37 | $-0.63 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | · | · | · | · | 0.0 |
| Cari Oran | 1.1 | 0.9 | 0.9 | 1.4 | 3.4 |
| Cari Oran | 1.0 | 0.7 | 0.5 | 1.1 | 3.2 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-10M | $5M | $-39M | $-18M | $-29M |
Kurumsal Sahipler (13F) 30 dosya · $4.2M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
30
Tutulan Değer
$4.2M
Yeni pozisyonlar
7
Çıkan pozisyonlar
5
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 7 (0 önceki Ç'ye göre) | 5 (-2 önceki Ç'ye göre) | 11 (+5 önceki Ç'ye göre) | 4 (+1 önceki Ç'ye göre) | +277K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.352.250 | 640.877 | 32,42% | Hisse senetleri |
| VANGUARD GROUP INC | $1.009.492 | 523.053 | 24,20% | Hisse senetleri |
| AMH Equity Ltd | $487.983 | 232.373 | 11,70% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $295.642 | 140.093 | 7,09% | Hisse senetleri |
| US BANCORP \DE\ | $255.141 | 120.920 | 6,12% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $192.578 | 91.269 | 4,62% | Hisse senetleri |
| BlackRock, Inc. | $135.564 | 64.248 | 3,25% | Hisse senetleri |
| STATE STREET CORP | $100.046 | 47.415 | 2,40% | Hisse senetleri |
| JANE STREET GROUP, LLC | $76.154 | 36.092 | 1,83% | Hisse senetleri |
| NORTHERN TRUST CORP | $72.181 | 34.209 | 1,73% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $34.547 | 17.900 | 0,83% | Hisse senetleri |
| LPL Financial LLC | $31.416 | 14.889 | 0,75% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $31.363 | 14.864 | 0,75% | Hisse senetleri |
| StoneX Group Inc. | $24.745 | 11.153 | 0,59% | Hisse senetleri |
| Objectivity Squared, LLC | $23.031 | 10.915 | 0,55% | Hisse senetleri |
| Farther Finance Advisors, LLC | $19.940 | 9.450 | 0,48% | Hisse senetleri |
| UBS Group AG | $14.369 | 6.810 | 0,34% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $6.203 | 2.940 | 0,15% | Hisse senetleri |
| Bay Harbor Wealth Management, LLC | $2.865 | 1.358 | 0,07% | Hisse senetleri |
| IFS Advisors, LLC | $2.004 | 950 | 0,05% | Hisse senetleri |
| SBI Securities Co., Ltd. | $1.361 | 645 | 0,03% | Hisse senetleri |
| JONES FINANCIAL COMPANIES LLLP | $828 | 396 | 0,02% | Hisse senetleri |
| Caitong International Asset Management Co., Ltd | $557 | 264 | 0,01% | Hisse senetleri |
| BARCLAYS PLC | $523 | 248 | 0,01% | Hisse senetleri |
| CALDWELL SUTTER CAPITAL, INC. | $211 | 100 | 0,01% | Hisse senetleri |
| MATHER GROUP, LLC. | $177 | 84 | 0,00% | Hisse senetleri |
| HRT FINANCIAL LP | $47 | 22.430 | 0,00% | Hisse senetleri |
| Virtu Financial LLC | $33 | 15.803 | 0,00% | Hisse senetleri |
| PRICE T ROWE ASSOCIATES INC /MD/ | $29 | 13.318 | 0,00% | Hisse senetleri |
| Inspire Investing, LLC | $26 | 14 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 8 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Roger L. Hawley, The Hawley Family Trust Dated October 22, 2004 ×4 başvurular | 01 Nisan 2020 | · | İlk başvuru | Yönetim kurulu kampanyası | SEC |
| Sabrina Martucci Johnson, Vincent S. Johnson and Sabrina M. Johnson Family Trust Dated February 14, 2005, Vincent S. Johnson ×3 başvurular | 21 Şubat 2020 | · | İlk başvuru | · | SEC |
| Mark Walters, Walters Family Trust Dated January 15, 2009, Nancy Walters ×2 başvurular | 16 Nisan 2019 | · | İlk başvuru | · | SEC |
| Lisa Walters-Hoffert, Lisa Walters-Hoffert Survivor’s Trust dated October 31, 2002 ×2 başvurular | 15 Nisan 2019 | · | İlk başvuru | · | SEC |
| Polaris Venture Partners IV, L.P. (“PVP IV”), Polaris Venture Partners Entrepreneurs’ Fund IV, L.P. (“PVPE IV”), Polaris Venture Management Co. IV, L.L.C. (“PVM IV”), Jonathan A. Flint, Terrance G. McGuire ×2 başvurular | 14 Şubat 2019 | · | İlk başvuru | · | SEC |
| Alan Crane ×2 başvurular | 14 Şubat 2019 | · | İlk başvuru | · | SEC |
| Polaris Venture Partners V, L.P. (“PVP V”), Polaris Venture Partners Entrepreneurs’ Fund V, L.P. (“PVPE V”), Polaris Venture Partners Founders’ Fund V, L.P. (“PVPFF V”), Polaris Venture Partners Special Founders’ Fund V, L.P. (“PVPSFF V”), Polaris Venture Management Co. V, L.L.C. (“PVM V”), Jonathan A. Flint, Terrance G. McGuire ×2 başvurular | 14 Şubat 2019 | · | İlk başvuru | · | SEC |
| Daré Bioscience, Inc. | 28 Mart 2017 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 30 içeriden öğrenenler · 13 yöneticiler · 17 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Christopherd T Guiffre | Chief Executive Officer | 06 Ocak 2017 A | 12.489 | 0 | 0 | $0 |
| Oliver Fetzer | President and CEO | 24 Haziran 2014 A | 30.000 | 0 | 0 | $0 |
| Lisa Walters-Hoffert | Chief Financial Officer | 24 Ocak 2023 A | 443.512 | 0 | 0 | $0 |
| Gregg Beloff | CFO | 05 Ocak 2017 A | · | 0 | 0 | $0 |
| Sabrina Martucci Johnson | Chef Executive Officer | 18 Şubat 2026 A | 962.062 | 0 | 0 | $0 |
| Mardee Haring-Layton | Chief Accounting Officer | 30 Ocak 2026 A | · | 0 | 0 | $0 |
| John A Fair | Chief Commercial Officer | 12 Mart 2024 A | · | 0 | 0 | $0 |
| Scott Eliasof | SVP, Chief Scientific Officer | 05 Ocak 2017 A | · | 0 | 0 | $0 |
| Alejandra Carvajal | VP, General Counsel | 05 Ocak 2017 A | · | 0 | 0 | $0 |
| Adrian Senderowicz | SVP, Chief Medical Officer | 05 Ocak 2017 A | · | 0 | 0 | $0 |
| James E Oneill | Principal Accounting Officer | 05 Ocak 2017 A | 2.098 | 0 | 0 | $0 |
| Karen Lynn Roberts | Sr VP Finance & Administrat | 05 Şubat 2015 A | · | 0 | 0 | $0 |
| Edward Graeme Garmey | Sr. VP, Chief Medical Officer | 05 Şubat 2015 A | · | 0 | 0 | $0 |
| Jessica D. Grossman | Yönetim kurulu üyesi | 30 Haziran 2026 A | 26.066 | 0 | 0 | $0 |
| Gregory W Matz | Yönetim kurulu üyesi | 30 Haziran 2026 A | 30.847 | 0 | 0 | $0 |
| Susan L. Kelley | Yönetim kurulu üyesi | 30 Haziran 2026 A | 23.696 | 0 | 0 | $0 |
| Robin Joan Steele | Yönetim kurulu üyesi | 30 Haziran 2026 A | 47.055 | 0 | 0 | $0 |
| William H Rastetter | Yönetim kurulu üyesi | 30 Haziran 2026 A | 39.721 | 0 | 0 | $0 |
| Sophia Nnenna Ononye-Onyia | Yönetim kurulu üyesi | 21 Haziran 2023 A | · | 0 | 0 | $0 |
| Cheryl R Blanchard | Yönetim kurulu üyesi | 21 Haziran 2023 A | · | 0 | 0 | $0 |
| Paul A Friedman, M.D. | Yönetim kurulu üyesi | 03 Nisan 2017 A | 18.819 | 0 | 0 | $0 |
| Stuart A Arbuckle | Yönetim kurulu üyesi | 03 Ocak 2017 A | 13.104 | 0 | 0 | $0 |
| David Ross Parkinson | Yönetim kurulu üyesi | 03 Ocak 2017 A | 28.488 | 0 | 0 | $0 |
| William Mckee | Yönetim kurulu üyesi | 03 Ocak 2017 A | 3.418 | 0 | 0 | $0 |
| David R Walt | Yönetim kurulu üyesi | 03 Ocak 2017 A | 193.700 | 0 | 0 | $0 |
| Alan L Crane | Yönetim kurulu üyesi | 22 Haziran 2016 A | 4.771.739 | 0 | 0 | $0 |
| Steven Edward Hall | Yönetim kurulu üyesi | 26 Haziran 2015 A | 2.356.227 | 0 | 0 | $0 |
| CVF, LLC | 10% sahip | 07 Nisan 2015 P | 2.592.577 | 0 | 0 | $0 |
| Roger Hawley | · | 13 Haziran 2019 A | 944.956 | 0 | 0 | $0 |
| Rock Springs Capital Management LP | · | 15 Nisan 2014 C | 464.365 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 3 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
DARE Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 9 analist
AL
Medyan hedef
$8.00
+849,2%
2 22,2%
Güçlü Al
6 66,7%
Al
1 11,1%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
3 analist · 2026-10-03Ortalama hedef $8.33 +888,8%
← Tüm hedeflerin altında
Mevcut fiyat $0.84
Düşük$5.00
Ortalama$8.33
Yüksek$12.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| DARE | $28M | -1.6 | 10429.4% | -1300.7% | 270.9% | · |
| RKTO | · | · | · | · | · | · |
| LPCN | $49M | -4.8 | -82.3% | -487.1% | -60.9% | · |
| TVRD | $40M | -1.3 | -66.0% | · | -67.6% | · |
| BFRI | · | · | · | · | · | · |
| CTXR | · | -0.4 | · | · | · | · |
| HIND | $20M | -0.7 | 24.4% | -3209.7% | -411.1% | 68.4% |
| CALC | · | -3.3 | -29.7% | · | · | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 13, 2026